SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021497
Filing Date
2023-05-12
Accepted
2023-05-12 07:20:01
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lyra-20230331.htm   iXBRL 10-Q 2377715
2 EX-31.1 lyra-ex31_1.htm EX-31.1 21248
3 EX-31.2 lyra-ex31_2.htm EX-31.2 21240
4 EX-32.1 lyra-ex32_1.htm EX-32.1 12057
5 EX-32.2 lyra-ex32_2.htm EX-32.2 12046
  Complete submission text file 0000950170-23-021497.txt   7258854

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyra-20230331_def.xml EX-101.DEF 134477
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyra-20230331_pre.xml EX-101.PRE 295666
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyra-20230331.xsd EX-101.SCH 50075
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyra-20230331_cal.xml EX-101.CAL 35372
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyra-20230331_lab.xml EX-101.LAB 409855
51 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20230331_htm.xml XML 1131345
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39273 | Film No.: 23913148
SIC: 3841 Surgical & Medical Instruments & Apparatus